CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3.
Lei YangYi ChenNing LiuYanwen LuWenliang MaZhenhao YangWeidong GanDongmei LiPublished in: Molecular cancer (2022)
CircMET promotes the development of NONO-TFE3 tRCC, and the regulation to both CDKN2A and SMAD3 of circMET was revealed. CircMET has the potential to serve as a novel target for the molecular therapy of NONO-TFE3 tRCC as well as the other cancer with high-expressing circMET.